company background image
SNYR

Synergy CHC OTCPK:SNYR Stock Report

Last Price

US$0.0055

Market Cap

US$494.4k

7D

0%

1Y

-93.9%

Updated

16 Aug, 2022

Data

Company Financials
SNYR fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance2/6
Financial Health4/6
Dividends0/6

SNYR Stock Overview

Synergy CHC Corp. provides consumer health care, beauty, and lifestyle products in the United States, Canada, and the United Kingdom.

Synergy CHC Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Synergy CHC
Historical stock prices
Current Share PriceUS$0.0055
52 Week HighUS$0.17
52 Week LowUS$0.0001
Beta-1.77
1 Month Change0%
3 Month Changen/a
1 Year Change-93.88%
3 Year Change-97.66%
5 Year Change-98.55%
Change since IPO-99.73%

Recent News & Updates

Shareholder Returns

SNYRUS Personal ProductsUS Market
7D0%5.0%4.5%
1Y-93.9%-16.3%-8.9%

Return vs Industry: SNYR underperformed the US Personal Products industry which returned -18.1% over the past year.

Return vs Market: SNYR underperformed the US Market which returned -9.6% over the past year.

Price Volatility

Is SNYR's price volatile compared to industry and market?
SNYR volatility
SNYR Average Weekly Movementn/a
Personal Products Industry Average Movement10.6%
Market Average Movement7.6%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.1%

Stable Share Price: Insufficient data to determine SNYR's volatility over the past 3 months.

Volatility Over Time: Insufficient data to determine SNYR's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
201035Jack Rosshttps://synergychc.com

Synergy CHC Corp. provides consumer health care, beauty, and lifestyle products in the United States, Canada, and the United Kingdom. It offers brain health nutritional supplements under the FOCUSfactor brand name; lifestyle products and accessories, including tea, shakes, lollipops, supplements, apparel, and exercise accessories under the Flat Tummy brand name; anti-aging skincare products, such as serums and creams for exfoliating, skin repair, and rehydration, as well as hand soaps and hand sanitizers under the Hand MD brand name. The company sells its products through retailers and television advertising campaigns, as well as skincare products through online.

Synergy CHC Fundamentals Summary

How do Synergy CHC's earnings and revenue compare to its market cap?
SNYR fundamental statistics
Market CapUS$494.39k
Earnings (TTM)US$3.96m
Revenue (TTM)US$46.63m

0.1x

P/E Ratio

0.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
SNYR income statement (TTM)
RevenueUS$46.63m
Cost of RevenueUS$13.54m
Gross ProfitUS$33.09m
Other ExpensesUS$29.13m
EarningsUS$3.96m

Last Reported Earnings

Sep 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)0.044
Gross Margin70.97%
Net Profit Margin8.49%
Debt/Equity Ratio833.3%

How did SNYR perform over the long term?

See historical performance and comparison
We’ve recently updated our valuation analysis.

Valuation

Is SNYR undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SNYR?

Other financial metrics that can be useful for relative valuation.

SNYR key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue0.2x
Enterprise Value/EBITDA1.6x
PEG Ration/a

Price to Earnings Ratio vs Peers

How does SNYR's PE Ratio compare to its peers?

SNYR PE Ratio vs Peers
The above table shows the PE ratio for SNYR vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average6.5x
PMPG Premier Products Group
3.5xn/aUS$1.6m
INBP Integrated BioPharma
2.3xn/aUS$15.8m
CYAN Cyanotech
14.3xn/aUS$16.6m
MTEX Mannatech
6xn/aUS$37.9m
SNYR Synergy CHC
0.1xn/aUS$494.4k

Price-To-Earnings vs Peers: SNYR is good value based on its Price-To-Earnings Ratio (0.1x) compared to the peer average (6.5x).


Price to Earnings Ratio vs Industry

How does SNYR's PE Ratio compare vs other companies in the US Personal Products Industry?

Price-To-Earnings vs Industry: SNYR is good value based on its Price-To-Earnings Ratio (0.1x) compared to the US Personal Products industry average (20.1x)


Price to Earnings Ratio vs Fair Ratio

What is SNYR's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SNYR PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio0.1x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate SNYR's Price-To-Earnings Fair Ratio for valuation analysis.


Share Price vs Fair Value

What is the Fair Price of SNYR when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: SNYR ($0.01) is trading below our estimate of fair value ($0.19)

Significantly Below Fair Value: SNYR is trading below fair value by more than 20%.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies

Future Growth

How is Synergy CHC forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


12.6%

Forecasted Household industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Synergy CHC has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Discover growth companies

  • Examine whether Synergy CHC is trading at an attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Synergy CHC's filings and announcements here.

Past Performance

How has Synergy CHC performed over the past 5 years?

Past Performance Score

2/6

Past Performance Score 2/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


-3.6%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: SNYR has a high level of non-cash earnings.

Growing Profit Margin: SNYR became profitable in the past.


Past Earnings Growth Analysis

Earnings Trend: SNYR has become profitable over the past 5 years, growing earnings by -3.6% per year.

Accelerating Growth: SNYR has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: SNYR has become profitable in the last year, making it difficult to compare its past year earnings growth to the Personal Products industry (4.3%).


Return on Equity

High ROE: Whilst SNYR's Return on Equity (403.3%) is outstanding, this metric is skewed due to their high level of debt.


Discover strong past performing companies

Financial Health

How is Synergy CHC's financial position?

Financial Health Score

4/6

Financial Health Score 4/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: SNYR's short term assets ($19.5M) exceed its short term liabilities ($19.2M).

Long Term Liabilities: SNYR's short term assets ($19.5M) exceed its long term liabilities ($944.6K).


Debt to Equity History and Analysis

Debt Level: SNYR's net debt to equity ratio (788.8%) is considered high.

Reducing Debt: SNYR's debt to equity ratio has increased from 69.6% to 833.3% over the past 5 years.

Debt Coverage: SNYR's debt is well covered by operating cash flow (22.8%).

Interest Coverage: SNYR's interest payments on its debt are well covered by EBIT (4x coverage).


Balance Sheet


Discover healthy companies

Dividend

What is Synergy CHC current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate SNYR's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate SNYR's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if SNYR's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if SNYR's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as SNYR has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

4.6yrs

Average management tenure


CEO

Jack Ross (56 yo)

7.83yrs

Tenure

US$1,110,000

Compensation

Mr. Jack Ross has been the Chairman and Chief Executive Officer at Synergy CHC Corp. since October 27, 2014. He served as the Chief Financial Officer at Synergy CHC Corp. since August 17, 2018 until July 2...


CEO Compensation Analysis

Compensation vs Market: Insufficient data to establish whether Jack's total compensation is reasonable compared to companies of similar size in the US market.

Compensation vs Earnings: Jack's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: SNYR's management team is considered experienced (4.6 years average tenure).


Board Members

Experienced Board: SNYR's board of directors are considered experienced (7.7 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Synergy CHC Corp.'s employee growth, exchange listings and data sources


Key Information

  • Name: Synergy CHC Corp.
  • Ticker: SNYR
  • Exchange: OTCPK
  • Founded: 2010
  • Industry: Personal Products
  • Sector: Household
  • Implied Market Cap: US$494.389k
  • Shares outstanding: 89.89m
  • Website: https://synergychc.com

Number of Employees


Location

  • Synergy CHC Corp.
  • 865 Spring Street
  • Westbrook
  • Maine
  • 4092
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/08/16 00:00
End of Day Share Price2022/06/06 00:00
Earnings2021/09/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.